US Representative

Mike Flood 2025-2026 Regular Session - Authored & Sponsored Legislation (Page 6)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB4864

Introduced
8/1/25  
Ethanol for America Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB502

Introduced
1/16/25  
Refer
1/16/25  
Protecting Infrastructure Investments for Rural America Act This bill modifies the definition of rural area that is used for the Rural Surface Transportation Grant Program and adds provisions for small communities.As background, the grant program supports projects that improve and expand the surface transportation infrastructure in rural areas. Eligible applicants for the grant program include states, regional transportation planning organizations, local governments, and tribal governments.For purposes of the program, the bill defines rural area as an area outside an urbanized area that has a population of 30,000 or less. Current law requires a rural area to be outside of an urbanized area with a population of over 200,000.The bill includes provisions for small communities (i.e., an area outside an urbanized area and that has a population of 5,000 or less). The bill sets the maximum federal cost-share at 90% for project grants carried out in a small community. The Department of Transportation (DOT) must use at least 5% of the program's annual funds to provide grants for projects in small communities. The bill also removes the prohibition against DOT using more than 10% of program funds for grants that are under $25 million.Further, program grants may be used for highway, road, bridge, or tunnel projects that would benefit the economic development or quality of life for citizens of the local community.The bill also specifies that the program's goals include the generation of economic growth and development in rural areas. 
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB539

Introduced
1/16/25  
Chiropractic Medicare Coverage Modernization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB575

Introduced
1/21/25  
Refer
1/21/25  
Increased TSP Access Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB637

Introduced
1/22/25  
911 SAVES Act Supporting Accurate Views of Emergency Services Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB654

Introduced
1/23/25  
Taking Account of Bureaucrats' Spending Act of 2025 or the TABS Act of 2025 This bill restructures the Consumer Financial Protection Bureau and renames it as the Consumer Financial Empowerment Agency. The new agency is established as an independent agency outside of the Federal Reserve System.The bill also changes the funding structure of the agency by prohibiting the transfer of funds to the agency from the Federal Reserve System and by authorizing congressional appropriations for FY2026-FY2027.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB685

Introduced
1/23/25  
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB7

Introduced
1/22/25  
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB703

Introduced
1/23/25  
Main Street Tax Certainty Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB710

Introduced
1/23/25  
Regulation Decimation Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB759

Introduced
1/28/25  
Federal Firefighters Families First Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB867

Introduced
1/31/25  
IGO Anti-Boycott Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB879

Introduced
1/31/25  
Medicare Patient Access and Practice Stabilization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB909

Introduced
2/4/25  
Crime Victims Fund Stabilization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB925

Introduced
2/4/25  
Dismantle DEI Act of 2025